Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2014 August;55(4) > The Journal of Cardiovascular Surgery 2014 August;55(4):461-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS  LATEST DEVELOPMENTS IN SFA MANAGEMENT 

The Journal of Cardiovascular Surgery 2014 August;55(4):461-4

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Prime time for drug eluting balloons in SFA interventions?

Brodmann M.

Division of Angiology, Medical University of Graz, Graz, Austria


PDF


Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite enormous improvements in device and treatment technology the long-term patency rate and clinical benefit of endovascular treatment in the respective vascular bed is not satisfying. Drug coated balloon technology as a treatment option in femoropopliteal disease has shown encouraging results in first-in-man trials, which have now been proven in large randomized controlled trials.

top of page